Tenax Therapeutics Inc. Common Stock (TENX)

Stock · NASDAQ · Health Care

$2.13as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Resistance level

$11.37

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

TENX
Tenax Therapeutics Inc. Common Stock
$2.13
▼ 2.74%
Market cap $498.11MP/E —
OVID
Ovid Therapeutics Inc. Common Stock
$2.81
▼ 4.10%
Market cap $494.60MP/E —
AQST
Aquestive Therapeutics Inc. Common Stock
$5.02
▼ 2.71%
Market cap $491.83MP/E —
EOLS
Evolus Inc. Common Stock
$8.89
▲ 0.06%
Market cap $487.98MP/E —
$3.86$9.12
QTTB
Q32 Bio Inc. Common Stock
$15.01
▼ 7.06%
Market cap $482.18MP/E 15.71
$1.62$23.57
SGMT
Sagimet Biosciences Inc. Series A Common Stock
$10.55
▼ 1.86%
Market cap $539.71MP/E —
$4.5$11.15
RZLT
Rezolute Inc. Common Stock (NV)
$4.62
▼ 7.23%
Market cap $452.57MP/E —
$1.07$11.46

Symbol	Market cap	P/E ratio	Price	1D	52-week range
TENX Tenax Therapeutics Inc. Common Stock	$498.11M	—	$2.13	▼ 2.74%
OVID Ovid Therapeutics Inc. Common Stock	$494.60M	—	$2.81	▼ 4.10%
AQST Aquestive Therapeutics Inc. Common Stock	$491.83M	—	$5.02	▼ 2.71%
EOLS Evolus Inc. Common Stock	$487.98M	—	$8.89	▲ 0.06%	$3.86$9.12
QTTB Q32 Bio Inc. Common Stock	$482.18M	15.71	$15.01	▼ 7.06%	$1.62$23.57
SGMT Sagimet Biosciences Inc. Series A Common Stock	$539.71M	—	$10.55	▼ 1.86%	$4.5$11.15
RZLT Rezolute Inc. Common Stock (NV)	$452.57M	—	$4.62	▼ 7.23%	$1.07$11.46

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.